March 6, 2008 - Axellis Ltd., the UK- and US-based medical technology company, has completed acquisitions of three software solutions business as part of the company’s strategy to position itself as a global provider of specialist hardware and software solutions for oncology and cardiology.

The companies that Axellis purchased have a full suite of complimentary technologies that will support and add value to today’s Oncology and cardiology programmes.

March 6, 2008 - The third annual Medical Device Regulatory, Reimbursement and Compliance Congress (Device Congress) to be held on the campus of Harvard University March 26-28 2008, will address how to satisfy the FDA, CMS, OIG, Congress, payers, providers and patients.

March 5, 2008 - Edwards Lifesciences Corp. reported that the first three human implants of the next-generation Edwards transcatheter aortic heart valve were performed at St. Paul's Hospital in Vancouver, British Columbia, marking the progression of minimally-invasive valve therapy.

February 5, 2008 - Doctors completed the first implant of Boston Scientific’s COGNIS cardiac resynchronization therapy defibrillator (CRT-D), which reportedly represents an entirely new platform to treat heart failure.

March 4, 2008 – MEDRAD sales revenues grew to $525 million in 2007, an increase of 10 percent over the previous year, which is expected to grow further should the merger with Possis be completed.

March 3, 2008 - Boston Scientific Corp. received CE Mark approval of its ACUITY Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, marking the company�s seventh U.S. or European regulatory approval in the past nine weeks.

For patient monitoring systems not integrated with PiCCO-Technology, Pulsion Medical Systems offers the PiCCO parameters through a connection to a PiCCO plus Device.

The PiCCO plus device features: automatic catheter detection; use of room temperature as well as iced injectate; simplified, organ-related, graphical user interface; extended trend display for all parameters - up to 5 days; illuminated large display; individual parameter configuration; and battery backup.

Edwards Lifesciences provides The Vigilance II monitor, which is designed to gives users the ability to present complex hemodynamic data in a simplified way to paint a clearer picture of the patient’s hemodynamic status.
Features include:
* Continuous CO, SvO2, EDV, SVR and other measured and derived parameters are presented on customized displays selected by the clinician.
* Onscreen, customized trend, data relationship and stat displays provide a complete picture of blood flow and tissue oxygenation for precision patient management.

March 4, 2008 - Visage Imaging will unveil its Visage Thin Client solutions portfolio, and demonstrate scalability for integrated 2D, 3D and 4D advanced visualization and other new tools for cardiology, radiology and other subspecialties, at the European Congress of Radiology (ECR) in Vienna, Austria, March 7-10.

March 4, 2008 - By using a dual-source technique on a single computed tomography (CT) system, a research team at the Medical University of South Carolina’s (MUSC) Heart & Vascular Center was able to make a comprehensive diagnosis of heart disease, according to a report published in the current issue Circulation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now